
A fund built on proven fundamentals. This is the strategy defining our approach to backing late-stage Kiwi companies with global ambition.
Over the last 20 years, we've built the relationships and reputation to secure access to New Zealand's most consequential companies – Halter, Crimson, Hnry, Substack, and Wayve among them.
Growth Fund III is a diversified venture fund backing late-stage Kiwi companies at the inflection point between promising and world-defining.





Growth Fund III is built on distinct advantages positioning Icehouse Ventures to find, access, and back New Zealand's most promising companies.

Growth-stage companies have validated product-market fit and established revenue, meaning shorter time horizons and reduced risk compared to early-stage investing.

Big companies come from small companies. Backing ~50% of New Zealand's startups since 2017 means arriving at growth rounds with the relationships, insights, and follow-on rights to back the ones that break through.

Relationships with founders built over two decades, across 380+ investments, provide proprietary insights into company performance, round timing, and growth trajectories.

20+ years backing New Zealand's most exceptional founders. 380+ companies invested. The country's largest deal team.

With Icehouse Ventures since our angel network days, growing alongside the firm to over $1b AUM.

An EHF fellow who raised his first fund in 2016 and has built a vibrant Chinese community and one of NZ's most diverse investor networks.

Drawn to the optimism of founders tackling seemingly insurmountable global problems, a three-month internship turned into a decade-long career.

A founder and investor of over a decade, backing NZ's most exceptional early-stage entrepreneurs to scale globally.

From top-tier law firms to senior exec roles in global tech, Jo brings rare commercial rigour backing Kiwi founders.
If you are considering allocating capital to venture as part of your portfolio, please share your details and one of our team will be in touch.